The Sunday announcement by FDA Commissioner Dr. Stephen A Hahn that convalescent plasma had received emergency approval quickly sparked much controversy and serious concern in the medical community. While stating that the treatment reduced deaths by 35%, the data does not support such a claim. We have two choices to…

In this episode of Reimagining Healthcare and IT, Tom Koulopoulos and I explore the importance of workflow in healthcare and its impact on clinical and operational outcomes. We also review the value of embedding analytics in the EHR to facilitate the use of analytics in direct patient care. (Length — 18:47) About — Reimagining Healthcare and IT is a regular videocast hosted by Tom Koulopoulos and Barry P Chaiken, MD where they discuss healthcare information technology topics.

Our country now faces the most significant public health crisis in more than a century. The COVID-19 virus has upended our lives and put all of us at risk for illness. As we approach the Fall, our thoughts turn to our children and their need to return to school. We…

In my first two articles on our road to recovery, I covered the first two phases of the COVID-19 pandemic. In them I shared my thoughts on how provider organizations could restart their service lines and expand their operations. Phase 3 of the pandemic is defined as the time when…

As I write this at the end of March, I am confronted with a world turned upside down. The COVID-19 pandemic has changed every part of my daily routine, limiting my trips to the grocery store, physically distancing me from family, friends, and colleagues, and forcing me to work from…

In my first article on a Provider Road to Recovery I shared the steps provider organizations needed to take to respond to the needs of patients who delayed elective care due to the COVID-19 pandemic. …

The American Hospital Association estimates the lost revenue to hospitals from the pandemic to be $50.7 bil. per month or $202.6 bil. over the four-month period March 1 through June 30, 2020. …

The inherent nature of patient care requires making a choice. What therapy will help the patient get better? What is the probability the drug will cure the disease? What are the risks? Can the chemotherapy lead to injury or death? Both clinicians and their patients are faced with these options…

A crisis has a way of focusing the mind. With millions infected and hundreds of thousands of dead from SARS-CoV-2 infections, thousands of life science company and university center researchers from around the world are working tirelessly to develop a COVID-19 vaccine. In normal times, these researchers would work independently…